A handful of biotechs, including Moderna, are betting that simple infusions with mRNA could supercharge immune cells to fight cancer and other diseases in what would be a fresh take on CAR-T cell...
Carisma Therapeutics, emerging as a trailblazer in the biotech industry, is particularly noteworthy for its innovative approach to cancer treatment.
Carisma Therapeutics said on Tuesday that it will begin a Phase I clinical trial of its CAR monocyte therapy CT-0525 in HER2-positive solid tumors.
Immunotherapy has revolutionized cancer treatment, offering promising avenues beyond traditional methods. Recent breakthroughs showcased at the Society for Immunotherapy of Cancer’s (SITC) annual meeting have spotlighted innovative approaches, notably chimeric antigen receptor macrophage...